[1]李庆岗　程　岗　张剑宁.血药浓度监测在万古霉素治疗MRSA颅内感染中的价值[J].中国临床神经外科杂志,2021,26(04):243-245.[doi:10.13798/j.issn.1009-153X.2021.04.007]
　LI Qing-gang,Cheng Gang,ZHANG Jian-ning..Value of blood drug concentration monitoring in vancomycin treatment for patients with intracranial infection caused by MRSA[J].,2021,26(04):243-245.[doi:10.13798/j.issn.1009-153X.2021.04.007]
点击复制

血药浓度监测在万古霉素治疗MRSA颅内感染中的价值()
分享到：

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
26
期数:
2021年04期
页码:
243-245
栏目:
论著
出版日期:
2021-04-25

文章信息/Info

Title:
Value of blood drug concentration monitoring in vancomycin treatment for patients with intracranial infection caused by MRSA
文章编号:
1009-153X（2021）04-0243-03
作者:
李庆岗　程　岗　张剑宁
100048 北京，解放军总医院第一医学中心神经外科医学部（李庆岗、程　岗、张剑宁）；102445，北京北亚骨科医院神经外科（李庆岗）
Author(s):
LI Qing-gang;  Cheng Gang;  ZHANG Jian-ning.
Department of Neurosurgery, The First Medical Center of PLA General Hospital, Beijing 100048, China
关键词:
颅内感染; 耐甲氧西林金黄色葡萄球菌（MRSA）; 万古霉素; 血药浓度监测
Keywords:
Intracranial infection;  Vancomycin;  Methicillin-resistant staphylococcus aureus (MRSA);  Blood drug concentration
分类号:
R 739.41; Q 786
DOI:
10.13798/j.issn.1009-153X.2021.04.007
文献标志码:
A
摘要:
目的 探讨血药浓度监测在万古霉素治疗耐甲氧西林金黄色葡萄球菌（MRSA）颅内感染中的价值。方法 回顾性分析2017年5月至2019年10月收治的75例MRSA颅内感染的临床资料。根据血药浓度分为低浓度组（30例，谷浓度10~14 mg/L）和高浓度组（45例，谷浓度15~20 mg/L）。结果 高浓度组有效率（82.22%，37/45）明显高于低浓度组（60.00%，18/30；P<0.05）。低浓度组发生不良反应28例，肝功能异常1例，皮疹1例；高浓度组发生不良反应39例、肝功能异常2例、皮疹3例、中性粒细胞减少1例；调整给药方案后，均恢复正常。两组不良反应发生率无统计学差异（P>0.05）。两组均未出现耳毒性、肾毒性不良反应。多因素logistic回归分析显示，万古霉素谷浓度<15 mg/L、肾小球滤过率<60 ml/min、血肌酐≥133 μmol/L、用药时间≥2周是万古霉素治疗无效的独立危险因素（P<0.05）。ROC曲线分析显示，万古霉素谷浓度预测疗效的曲线下面积为0.778（95%置信区间0.648~0.905）。万古霉素谷浓度≥15.91 mg/L预测治疗有效的敏感性为0.673，特异性为0.802。结论 万古霉素治疗MRSA颅内感染，谷浓度在15~20 mg/L的临床疗效更好，同时需关注治疗时间、血肌酐和肾小球滤过率等指标。
Abstract:
Objective To explore the value of blood drug concentration monitoring in the vancomycin treatment for the patients with intracranial infection caused by methicillin-resistant staphylococcus aureus (MRSA). Methods The clinical data of 75 patients with intracranial infection caused MRSA who were admitted to our hospital from May 2017 to October 2019 were analyzed retrospectively. The blood drug concentration monitoring was performed on all the patients. Results The trough concentration of vancomycin ranged from 10 mg/L to 14 mg/L in 30 patients (low concentration group) and from 15 mg/L to 20 mg/L in 45 patients (high concentration group). The clinical effective rate of high concentration group (82.22%, 37/45) was significantly higher than that (60.00%, 18/30) of low high concentration group (P<0.05). There were no signifcant differences in the rates of adverse reactions, abnormal liver function, skin rash, and neutropenia between the two groups (P>0.05). No nephrotoxicity or ototoxicity occurred in the two groups. Multivariate logistic regression analysis showed that vancomycin trough concentration <15 mg/L, glomerular filtration rate <60 ml/min, serum creatinine ≥133 μmol/L, and medication time ≥2 weeks were independent risk factors for the ineffectiveness of vancomycin treatment (P<0.05). ROC curve analysis showed that the area under curve for predicting the efficacy of vancomycin trough concentration was 0.778 (95% confidence interval 0.648~0.905). The sensitivity and specificity of trough concentration of vancomycin ≥15.91 mg/L to predict therapeutic effectiveness were 0.673 and 0.802, respectively. Conclusions When the vancomycin is used to treat MRSA intracranial infections, the clinical effect is better as the trough concentration is in the range of 15~20 mg/L. At the same time, attention should be paid to the indicators such as treatment time, serum creatinine and glomerular filtration rate.

参考文献/References:

[1] 宣娟娟，姚　钧，徐网兰. 万古霉素敏感性降低的MRSA菌血症患者30 d病死率的危险因素分析[J]. 中国医师杂志，2019，21（12）：1882-1884.（下转第249页）（上接第245页）
[2] 王月芳，钟　伟，陈东琳. 利奈唑胺、替考拉宁及万古霉素治疗院内MRSA肺炎的临床观察[J]. 中国药房，2016，27（26）：3708-3710.
[3] 张立平，何囡囡，曹　雯，等. 危重患者万古霉素血药谷浓度与肾损害的相关性研究[J]. 中国急救医学，2014，34（11）：1022-1025.
[4] 梁晓宇，吴菊芳，杨敏婕，等. 万古霉素治疗药物浓度监测队列研究[J]. 中国感染与化疗杂志，2015，15（5）：472-478.
[5] American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia [J]. Am J Respir Crit Care Med, 2005, 171(4): 388-416.
[6] Martin JH, Norris R, Barras M, et al. Therapeutic monitoringof vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infec-tious Diseases Society of America, and the Society of Infec-tious Diseases Pharmacists [J]. Clin Biochem Rev, 2010, 31 (1): 21-24.
[7] Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guide-lines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary [J]. Clin Infect Dis, 2011, 52(3): 285-292.
[8] 张秀珍，倪宇星，俞云松，等. 万古霉素临床应用中国专家共识[J]. 中国新药与临床杂志，2011，30（8）：561-573.
[9] Clemens EC, Chan JD, Lynch JB, et al. Relationshipsbetween vancomycin minimum inhibitory concentration, dosing strategies, and outcomes in methicillin-resistant Staphylococcus aureusbacteremia [J]. Diagn Microbiol Infect Dis, 2011, 71(4): 408-414.
[10] Tunkel AR, Hasbun R, Bhim RAJA, et al. 2017 infectious diseases society of America’s clinical practice guidelines for healthcare-associated ventriculitis and meningitis [J]. Clin Infect Dis, 2017, 64(6): e34-e65.
[11] 中华医学会神经外科学分会. 中国神经外科重症患者感染诊治专家共识（2017）[J]. 中华医学杂志，2017，97（21）：1607-1614.
[12] 万古霉素临床应用剂量专家组. 万古霉素临床应用剂量中国专家共识[J]. 中华传染病学杂志，2012，30（11）：641-646.
[13] 吴　涛，袁先厚，江普查，等. 开颅术后颅内感染的临床诊治[J]. 中国临床神经外科杂志，2004，9（4）：433-434.

相似文献/References:

[1]裴红莎　刘宝来　聂晓奇　吉宏明　李军伟　郭建忠　邹　鹏　张刚利.磷霉素和头孢哌酮/舒巴坦钠序贯疗法治疗颅内多重耐药鲍曼不动杆菌感染的临床分析[J].中国临床神经外科杂志,2016,(04):232.[doi:10.13798/j.issn.1009-153X.2016.04.013]
[2]陈　俊　周赤忠　付　伟　潘德锐.开颅术后继发性颅内感染致脑梗死15例分析[J].中国临床神经外科杂志,2016,(01):40.[doi:10.13798/j.issn.1009-153X.2016.01.014]
[3]宋越群　于　剑　王莹莹.尿激酶灌洗对脑室出血患者脑室外引流术后颅内感染的影响[J].中国临床神经外科杂志,2016,(10):628.[doi:10.13798/j.issn.1009-153X.2016.10.022]
[4]张洪微,窦榕榕,渠雪红,等.血清降钙素原在开颅术后颅内感染早期诊断中的价值[J].中国临床神经外科杂志,2016,(12):756.[doi:10.13798/j.issn.1009-153X.2016.12.008]
　ZHANG Hong-wei,DOU Rong-rong,QU Xue-hong,et al.The value of serum procalcitonin to early diagnosis of acute bacterial intracranial infection after craniotomy[J].,2016,(04):756.[doi:10.13798/j.issn.1009-153X.2016.12.008]
[5]武元星　郝京京　王　强.血清及脑脊液降钙素原在神经外科术后颅内感染早期诊断中的应用[J].中国临床神经外科杂志,2017,(04):237.[doi:10.13798/j.issn.1009-153X.2017.04.010]
　WU Yuan-xing,HAO Jing-jing,WANG Qiang..Value of procalcitonin in serum and cerebrospinal fluid to diagnosis of intracranial infection early after craniotomy[J].,2017,(04):237.[doi:10.13798/j.issn.1009-153X.2017.04.010]
[6]袁　波　邢海涛　应建有　娄志刚　段勇刚　谭占国.鲍曼不动杆菌致颅内感染的临床特点及救治体会（附7例报道）[J].中国临床神经外科杂志,2017,(04):252.[doi:10.13798/j.issn.1009-153X.2017.04.017]
[7]刘荣华　段奎甲.颅脑术后颅内感染相关危险因素分析[J].中国临床神经外科杂志,2017,(06):407.[doi:10.13798/j.issn.1009-153X.2017.06.014]
　LIU Rong-hua,DUAN Kui-jia..Risk factors related to intracranial infection after craniotomy[J].,2017,(04):407.[doi:10.13798/j.issn.1009-153X.2017.06.014]
[8]乔建华　海　燕.内镜下经蝶入路切除垂体腺瘤术后颅内感染的危险因素分析[J].中国临床神经外科杂志,2017,(06):413.[doi:10.13798/j.issn.1009-153X.2017.06.016]
　QIAO Jian-hua,HAI Yan..Risk factors relate to intracranial infection after endoscope-assisted surgery through endonasal transsphenoidal approach for pituitary adenomas[J].,2017,(04):413.[doi:10.13798/j.issn.1009-153X.2017.06.016]
[9]郭　康　衡立君　孙树凯　张海红　贾　栋.内镜下经蝶术后颅内感染的危险因素分析[J].中国临床神经外科杂志,2017,(06):424.[doi:10.13798/j.issn.1009-153X.2017.06.020]
[10]毋江 杨红利 解旭鹏 王甲光.经鼻蝶入路垂体腺瘤切除术后严重颅内感染合并脑积水2例[J].中国临床神经外科杂志,2017,(10):734.[doi:10.13792017.09/j.issn.1009-153X.2017.10.025]

备注/Memo

备注/Memo:
基金项目：军队后勤科研计划课题（AHJ14J001）
通讯作者：张剑宁，E-mail： jnzhang2018@163.com
更新日期/Last Update: 2021-04-25